Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported a beneficial ownership of 8.6% of Clearwater Paper Corp's common stock as of December 31, 2025.

BlackRock, Inc. has reported a 5.1% beneficial ownership stake in Affirm Holdings Inc. Class A stock as of December 31, 2025.

BlackRock, Inc. has reported a beneficial ownership of 7.9% in Adaptive Biotechnologies Corp's common stock, totaling 11,992,448 shares.

BlackRock, Inc. has increased its beneficial ownership in Cogent Biosciences, Inc. to 6.5% of common stock, holding over 11.3 million shares.

BlackRock, Inc. has reported a 6.6% beneficial ownership stake in Bentley Systems Inc.'s Class B Stock as of December 31, 2025.

BlackRock, Inc. has reported a beneficial ownership of 6.5% in Gossamer Bio, Inc. common stock as of December 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership in Eledon Pharmaceuticals, Inc. has fallen to 4.6% of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.8% beneficial ownership stake in StoneCo Ltd.'s Class A Stock.

BlackRock, Inc. has reported a 15.0% beneficial ownership stake in Arrowhead Pharmaceuticals Inc., holding over 20 million shares as of December 31, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 12.1% in Consolidated Water Co. Ltd., holding 1,921,141 common shares as of December 31, 2025.

BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Arrivent Biopharma Inc., holding over 2.3 million common shares as of December 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.2% of Astera Labs Inc.'s common stock as of December 31, 2025.

BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Compass Therapeutics, Inc. as of December 31, 2025, as disclosed in a Schedule 13G filing dated January 21, 2026.

BlackRock, Inc. has reported a 7.2% beneficial ownership stake in Ares Management Corporation's Class A Stock as of December 31, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.3% beneficial ownership stake in Grupo Televisa SAB's common stock.

BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Bankwell Financial Group, Inc. as of December 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 12.5% beneficial ownership of Luxfer Holdings PLC's common stock, totaling 3,333,423 shares as of December 31, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 7.8% in quantum computing company IonQ, Inc. as of December 31, 2025.

BlackRock, Inc. has reported a beneficial ownership of 6.9% of Embraer S.A.'s common stock, totaling 50,955,237 shares, as of December 31, 2025.

BlackRock, Inc. has reported an 8.6% beneficial ownership stake in BorgWarner Inc. common stock as of December 31, 2025, through a Schedule 13G/A filing.

BlackRock, Inc. has reported a 6.5% beneficial ownership stake in Brazilian Electric Power Co.'s Preferred Class B1 Shares as of December 31, 2025.

BlackRock, Inc. has reported a 6.5% beneficial ownership stake in Kinross Gold Corp., holding 78,955,000 common shares as of December 31, 2025.

BlackRock, Inc. has disclosed an 11.2% beneficial ownership stake in Gates Industrial Corp plc, holding 28,830,770 shares of common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 6.5% beneficial ownership stake in Cogent Biosciences, Inc. as of December 31, 2025.

BlackRock, Inc. has reported an updated beneficial ownership of 9.3% of Camden Property Trust's common stock, holding 9,872,008 shares.

BlackRock, Inc. has reported an 8.4% beneficial ownership stake in Community Healthcare Trust Incorporated, holding 2,396,124 common shares.

BlackRock, Inc. has reported a 6.6% beneficial ownership stake in Oruka Therapeutics, Inc., holding over 3.1 million shares of common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 9.6% beneficial ownership stake in Owens Corning common stock as of December 31, 2025.

BlackRock, Inc. has reported a 5.00% beneficial ownership stake in Peoples Bancorp of North Carolina Inc. as of December 31, 2025.

BlackRock, Inc. has reported a 5.1% beneficial ownership stake in KORU Medical Systems Inc., holding 2,345,369 shares of common stock.